KAREN BOLDEN: Open Payments
NPI 1902465040 · BYHALIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79 in 5 payments from 4 companies in 2025. Trend: 2023 $19 · 2024 $17 · 2025 $79
Food & beverage: $79
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: OTEZLA, GVOKE HYPOPEN.
Industry payments across MS — which companies pay providers there.
